AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CELLUMED CO., LTD. Share Issue/Capital Change 2020

Dec 3, 2020

16644_rns_2020-12-03_69177a3f-1c7e-46e5-83d5-17b2ff39ac6f.html

Share Issue/Capital Change

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

셀루메드/증권 발행결과(자율공시)/(2020.12.03)증권 발행결과(자율공시)(제3자배정 유상증자)

증권 발행결과(자율공시)


1. 증권의 종류		주식회사 셀루메드 기명식 보통주
2. 발행방법		제3자배정 유상증자
3. 발행내역	발행예정주식수(주)	2,000,000
발행예정금액(원)	5,000,000,000
발행결정 최초 이사회결의일	2020-11-26
실제발행주식수(주)	2,000,000
실제발행금액(원)	5,000,000,000
납입일	2020-12-03
4. 상장예정 여부		예
5. 기타 투자판단에 참고할 사항		-
※관련공시	2020-12-02 유상증자결정(제3자배정 유상증자) 2020-11-26 유상증자결정(제3자배정)

AI assistant

CELLUMED CO., LTD. — Share Issue/Capital Change 2020

16644_rns_2020-12-03_69177a3f-1c7e-46e5-83d5-17b2ff39ac6f.html

More from CELLUMED CO., LTD.

CELLUMED CO., LTD. Share Issue/Capital Change 2020